Share on LinkedInShare on LinkedIn

ARTICLE · 29 AUGUST 2008

Taxation Law @ Gowlings - August 27, 2008

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On May 30th, 2008 the Tax Court of Canada (herein referred to as "Tax Court") ruled on one of Canada's most significant transfer pricing decisions, the case of GlaxoSmithKline Inc.

CanadaTax

Tax Court Of Canada Rules On Glaxo Case: Results And Implications

Introduction

On May 30th, 2008 the Tax Court of Canada (herein referred to as "Tax Court") ruled on one of Canada's most significant transfer pricing decisions, the case of GlaxoSmithKline Inc. (herein referred to as "GSK"). When examined from all avenues, the case yields important conclusions that both practitioners and multinational corporations alike should note when dealing with contentious transfer pricing issues.1

The purpose of this article is to not only examine the Tax Court's choice of methodology in coming to its decision, but also to consider the benefits of pursuing alternatives to litigation, such as Competent Authority.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from